Status:
COMPLETED
A Study of BRT-FC-83C for the Treatment of Atopic Dermatitis
Lead Sponsor:
Biomed Research & Technologies, Inc.
Conditions:
Atopic Dermatitis
Eligibility:
All Genders
18-50 years
Phase:
PHASE2
Brief Summary
The purpose of the study is to determine whether the topical application of BRT-FC-83C is effective in the treatment of mild to moderate atopic dermatitis.
Detailed Description
Atopic dermatitis is a common skin disease. BRT-FC-83C is a skin cream that does not contain corticosteroids or other anti-inflammatory components. It represents a novel class of skin barrier repair t...
Eligibility Criteria
Inclusion
- Clinically verified mild to moderate atopic dermatitis. Atopy diagnosis based on clinical scores of 3-7.5 based on the Rajka and Langeland criteria
- Men or women ages 18-50 years
- At least one mild to moderate atopic lesion involving no more than 20% Body Surface Area (BSA)
- Active atopic dermatitis for at least 3 years
- Willingness to cooperate and participate by following study requirements
- Written informed consent
Exclusion
- Individuals with actively oozing atopic lesions
- Individuals who are smokers
- Individuals with insulin-dependent diabetes mellitus
- Individuals that are known to be pregnant, nursing, or planning to become pregnant within the next six months after enrollment
- Individuals currently participating in another clinical usage study that would interfere with this study
Key Trial Info
Start Date :
January 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 1 2009
Estimated Enrollment :
32 Patients enrolled
Trial Details
Trial ID
NCT00883311
Start Date
January 1 2009
End Date
July 1 2009
Last Update
August 31 2010
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Thomas J. Stephens & Associates, Inc.
Colorado Springs, Colorado, United States, 80915